History
  • No items yet
midpage
450 F. App'x 326
5th Cir.
2011
Read the full case

Background

  • Tulane and Dr. Coy sued Ipsen, S.A. and Ipsen Pharma and Biomeasure for breach of contract related to BIM-51077 (Taspoglutide) and related IP licenses.
  • Plaintiffs alleged Biomeasure developed Taspoglutide under a 1990 RFA and a joint patent with Tulane, later licensed exclusively to Biomeasure.
  • Biometasure filed a Biomeasure-only patent resulting in the ‘186 patent later assigned to Ipsen Pharma; Ipsen then licensed development to a Swedish company.
  • District court preliminarily found no personal jurisdiction over Ipsen and Ipsen Pharma, allowed limited jurisdictional discovery, and dismissed without prejudice after briefing.
  • Plaintiffs appealed contending Ipsen Group control over Biomeasure created jurisdiction; court reviews de novo on undisputed facts for personal jurisdiction.
  • Ipsen and Ipsen Pharma are French, Biomeasure is Massachusetts-based and subsidiary of SUTREPA, with Ipsen indirectly owning Biomeasure.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the district court had personal jurisdiction over Ipsen and Ipsen Pharma Plaintiffs assert alter-ego/agency control imputes Biomeasure’s Louisiana contacts to Ipsen. Ipsen argues corporate formalities and lack of day-to-day control defeat imputability. No jurisdiction; no alter-ego or agency established.
Whether Biomeasure’s contacts can be imputed to Ipsen Control is sufficient to impute Biomeasure’s contacts to Ipsen. Observance of formalities and separate budgets undermine imputation. Imputation rejected.
Whether Ipsen Pharma is an alter ego of Biomeasure APA arrangement and patent/financing structure show unity. Arrangement does not establish alter ego under governing law. Alter ego not established.
Whether Biomeasure acted as Ipsen’s agent regarding the RFA or Licensing Agreement Biom**easure used Ipsen branding and funding links to show agency. No express authorization or reasonable reliance shown. No agency relationship found.

Key Cases Cited

  • Dickson Marine Inc. v. Panalpina, Inc., 179 F.3d 331 (5th Cir. 1999) (test for imputing jurisdictional contacts within a corporate group)
  • Jackson v. Tanfoglio Giuseppe S.R.L., 615 F.3d 579 (5th Cir. 2010) (Louisiana/Italian law approach to alter ego imputation; substantial factors required)
  • Hargrave v. Fibreboard Corp., 710 F.2d 1154 (5th Cir. 1983) (alter ego factors; 100% ownership alone is insufficient)
  • Dalton v. R & W Marine, Inc., 897 F.2d 1359 (5th Cir. 1990) (imputation considerations under corporate separateness)
  • Alpine View Co. v. Atlas Copco AB, 205 F.3d 208 (5th Cir. 2000) (economic control vs. day-to-day operations; alter ego framework)
  • Patin v. Thoroughbred Power Boats, Inc., 294 F.3d 640 (5th Cir. 2002) (interrelation of control and transactions in alter ego analysis)
  • United States v. Bestfoods, 524 U.S. 51 (1998) (parental liability; corporate form and control; corporate conduct under law)
Read the full case

Case Details

Case Name: Administrators of Tulane Educational Fund v. Ipsen, S.A.
Court Name: Court of Appeals for the Fifth Circuit
Date Published: Aug 30, 2011
Citations: 450 F. App'x 326; 10-30211
Docket Number: 10-30211
Court Abbreviation: 5th Cir.
Log In
    Administrators of Tulane Educational Fund v. Ipsen, S.A., 450 F. App'x 326